complaint·December 27, 2024

Continued from 9099... However, review of facility's Medication Administration Audit report and eMAR system indicates R1 had been receiving Sevelamer Carbonate 800mg 3 tablets 3 times per day from 11/27/24 through 12/16/24. On 12/17/24 R1's Sevelamer dosing was changed to 800mg 1 tablet 3 times per day. LPA review of facility's eMAR shows that on 12/16/24 the Sevelamer Carbonate 800mg 3 tablets 3 times per day was discontinued. However, CCL was never informed of the medication error and has never received an Incident report for the medication error ( deficiency cited, see 9099D ). LPA's review of R1's discharge papers, medications list of current prescriptions, and facility's eMAR all show that R1 received the incorrect dose of Sevelamar between the dates of 11/27/24 and 12/16/24. Therefore, based on LPA's record review, the preponderance of evidence standard has been met, therefore the above allegation is found to be SUBSTANTIATED. Deficiencies cited from the California Code of Regulations, Title 22, Division 6 of California Regulation and the Health and Safety Code. Appeal rights given and discussed with Administrator. Failure to correct the deficiency and/or repeat deficiencies within a 12 month period may result in civil penalties. Exit interview conducted with Administrator and a copy of this report was given